EFTA01961245.pdf

To: Boris Nikolic Cc: Jeffrey Epshtein[jeevacationegmail.com] From: ehud barak Sent Fri 8/16/2013 3:15:40 AM Subject Re: Parasight Ltd. Hi Boris P1 do . Especially if Parasight is considerably ahead of the wave. Will be glad to meet. I'm in NY on Sep 22-26 for the Clinton GI. Earlier in Sept in Bali and Nigeria. Just let me know what better works for you. Best Ehud Barak Sent from my iPad On 12 ma 2013, at 08:28, Boris Nikolic wrote: Will do my best. I just had chance to review — there might be a small complexity as we have been funding a company to develop similar system! Nevertheless I will do my best to help any way I can. Hope to see you soon in NYC or Tel Aviv or Davos! Boris From: ehud barak Sent: Sunday, August 11, 2013 10:24 PM To: Boris Nikolic Subject: Re: Parasight Ltd. Boris Thx. Waiting for your/Gene's response. Best Ehud Sent from my iPad On 12 AM 2013, at 07:40, Boris Nikolic wrote: Thank you Ehud! We will follow up for sure. I am sending this to Gene Walther who is leading diagnostics (including malaria diagnostics) at Bill and Melinda Gates Foundation. I think that Gene is on business travel and vacation right now so it might be some delay. EFTA_R1_00436037 EFTA01961245  Looking forward to learning more re this promising technology! All the best Boris From: ehud barak Sent: Sunday, August 11, 2013 9:51AM To: Boris Nikolic Subject: Fwd: Parasight Ltd. Dear Boris Attached as promised pl find Parasight presentation. P1 send me your initial response and we'll consider how to continue with them. Best Ehud Barak Sent from my iPhonc Begin forwarded message: From: Down Date: August 11, 2013, 18:52:33 GMT+03:00 To: Ehud BARAK <ehbarak I (agmail.com> Subject: Fwd: Parasight Ltd. Dear Dr. Nikolic, Parasight Ltd was founded two years ago in Israel in order to develop a platform technology for blood analysis and parasite detection. During this time, Parasight has focused on developing an innovative device for the accurate, rapid and inexpensive diagnosis of Malaria, suitable for POC and labs in Malaria-endemic EFTA_R1_00436038 EFTA01961246  countries as well as blood banks everywhere. The device is based on the latest technologies in the field of machine-vision together with breakthrough advances in sample preparation and staining. Following Mr. Barak's communication with you, we are proud to present the official report describing the results of our first clinical trial, which was conducted recently in India by the National Institute of Malaria Research. As the report indicates, our clinical accuracy is on par with PCR, but with ease of use and cost commensurate with RDTs. Additionally, I am attaching an executive summary describing the company. Our goal is to introduce Parasight's technology to the Gates Foundation in hopes of advancing the project and reaching the target population. As it happens, our co-founder and Chairman of the Scientific Advisory Board, Dr. Daniel Levner, is a Senior Staff Scientist at Harvard Medical School, so perhaps the best way to present our technology would be through a meeting. Please let me know what would be best for you. Thanks, 'foss' Pollak Chief EXOellthelt Officer Parasight Jerusalem I echnology Park. Israel EFTA_R1_00436039 EFTA01961247  I F *972 26737371 I M Yosai Pollak <PARASIGHT EXECUTIVE SUMMARY_VI.8.pdf> <CL-IN002_Report_signed.pdf> EFTA_R1_00438040 EFTA01961248